首页 > 市场调查报告书 > 医疗设备

导管

市场调查报告书

商品编码

1737153

2026 年至 2032 年胆道支架市场（按产品、最终用户、应用和地区划分）

Biliary Stents Market by Product (Biliary Metal Stents, Biliary Plastic Stents), End-User (Hospitals, Ambulatory Surgical Centers), Application (Biliopancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), & Region for 2026-2032

出版日期: 2025年05月09日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2026-2032年胆道支架市场评估

胆道疾病（例如胆道狭窄和胆结石）的发生率上升显着增加了对微创治疗的需求。人们对这些治疗的日益偏好推动了医疗机构对胆道支架的采用，从而扩大了市场规模。根据 Verified Market Research 分析师预测，胆道支架市场规模将在 2024 年下降至 3.4219 亿美元，并在预测期内达到 4.9036 亿美元。

胆道支架市场的快速扩张主要得益于支架技术的不断进步，从而改善了患者的治疗效果并减少了併发症。材料和设计的持续技术创新被认为是影响市场复合年增长率的关键因素，这将推动市场在2026年至2032年期间以4.60%的复合年增长率成长。

胆道支架市场定义/概述

胆道支架是用于治疗胆管阻塞的医疗设备，胆管阻塞通常由肿瘤、胆结石、胆管狭窄和其他疾病引起。这些支架被置入胆管，以确保胆汁从肝臟正常流向肠道，从而降低感染和其他併发症的风险。胆道支架的製造材料多种多样，包括塑胶和金属，每种类型的选择都基于患者的独特需求和阻塞的严重程度。胆道支架通常以微创手术置入，有助于缩短患者的恢復时间并减轻不适。

胆管炎和胆道闭锁等胆道疾病的发生率不断上升，是推动此类支架在医疗保健领域日益普及的驱动力。此外，药物释放型支架和生物分解性支架等支架技术的进步，预计也将成为推动胆道支架需求成长的主要因素。这些趋势预计将推动市场成长，提高全球患者治疗的可及性和有效性。

技术进步是否影响胆道支架市场的成长？

技术进步被认为是胆道支架市场成长的主要驱动因素。支架设计和材料的创新，例如全覆膜自膨式金属支架 (FCSEMS) 和生物可吸收支架的开发，正在不断整合，以改善患者治疗效果并最大限度地减少併发症。

这些进步被认为提高了手术成功率，减少了再次手术的需求，从而鼓励医疗保健提供者更多地采用这些技术。此外，随着医疗保健专业人员寻求更有效率、更有效的胆道阻塞解决方案，微创技术的引入有助于扩大这些设备在全球范围内的普及率。

影响胆道支架市场成长的主要限制因素有哪些？

胆道支架市场的成长受到支架置入手术高昂成本和专业医护人员短缺的限制。由于成本过高，一些地区，尤其是在新兴市场，难以获得先进的胆道支架留置技术。

此外，支架移位、感染和其他併发症的风险也被认为是限制胆道支架广泛应用的因素。此外，由于需要熟练的专家来执行该手术，这些市场限制进一步加剧，从而影响了市场成长，尤其是在医疗基础设施有限的地区。

Allium Medical Solutions
Boston Scientific Corporation
Conmed Corporation
Cook Medical LLC
Dispomedica GmbH
ELLA-CS
sro
ENDO-FLEX GmbH
Gadelius Medical KK
I Tech Co., Ltd.
Medi-Globe GmbH
Medi-Globe Technologies GmbH
Medtronic plc
Merit Medical Systems, Inc.
Micro-Tech（Nanjing）Co., Ltd.
Olympus Corporation
Optimed Medizinische Instrumente GmbH
Bard（acquired by BD）
Taewoong Medical Co., Ltd.
Xlumena, Inc.（acquired by Boston Scientific）

第十一章重大进展

产品发布/开发
合併与收购
业务扩展
伙伴关係与合作

第十二章附录

相关调查

简介目录

Product Code: 54505

Biliary Stents Market Valuation - 2026-2032

Rising incidences of biliary diseases, such as biliary strictures and gallstones, have significantly increased the demand for minimally invasive procedures. The growing preference for these treatments has driven the adoption of biliary stents across healthcare facilities, expanding the market size. According to the analyst from Verified Market Research, the Biliary Stents Market is estimated to reach a valuation of USD 490.36 Million over the forecast subjugating around USD 342.19 Million valued in 2024.

The rapid expansion of the biliary stents market is primarily driven by increasing advancements in stent technologies, leading to improved patient outcomes and reduced complications. The ongoing innovation in materials and design has been recognized as a key factor influencing the market's CAGR. It enables the market to grow at a CAGR of 4.60% from 2026 to 2032.

Biliary Stents Market: Definition/ Overview

Biliary stents are medical devices used to treat obstructions in the bile ducts, commonly caused by conditions such as tumors, gallstones, or strictures. These stents are inserted into the bile ducts to ensure proper bile flow from the liver to the intestine, reducing the risk of infection and other complications. Various materials, including plastic and metal, are employed in the production of biliary stents, with each type selected based on patient-specific needs and the severity of the obstruction. Minimally invasive procedures are typically used for the placement of biliary stents, contributing to faster recovery times and reduced patient discomfort.

The growing prevalence of biliary disorders, such as cholangitis and biliary atresia, has driven the increasing adoption of these stents across healthcare settings. Additionally, advancements in stent technology, including drug-eluting stents and biodegradable options, have been viewed as key factors contributing to the rising demand for biliary stents. These trends are expected to fuel market growth and enhance the accessibility and effectiveness of treatments for patients worldwide.

we are Technological Advancements Influencing the Growth of the iliary Stents Market?

Technological advancements have been recognized as a key driver in the growth of the biliary stents market. Innovations in stent design and materials, such as the development of fully covered self-expanding metal stents (FCSEMS) and bioabsorbable stents, are being integrated to enhance patient outcomes and minimize complications.

These advancements have been credited with increasing procedural success rates and reducing the need for repeat interventions, which has encouraged greater adoption by healthcare providers. Additionally, the implementation of minimally invasive techniques has been promoted as a contributing factor in expanding the global reach of these devices, as healthcare professionals seek more efficient and effective solutions for biliary obstructions.

What are the Major Restraints Affecting the Growth of the Biliary Stents Market?

The growth of the biliary stents market has been constrained by the high costs associated with stent placement procedures and the limited availability of specialized medical professionals. Access to advanced biliary stenting technology has been restricted in several regions due to the prohibitive costs, particularly in developing markets.

Furthermore, risks of stent migration, infection, and other complications have been noted as factors that may limit the widespread adoption of biliary stents. These restraints are further compounded by the requirement for skilled specialists to perform the procedures, a factor that has impacted the market growth, particularly in areas with limited healthcare infrastructure.

Category-Wise Acumens

What Factors Contribute to the Dominance of Hospitals as the Leading End-User Segment in the Biliary Stents Market?

According to VMR Analyst, the dominance of hospitals in the biliary stents market has been driven by several factors, including the availability of advanced medical infrastructure and the presence of skilled healthcare professionals. Hospitals are equipped with state-of-the-art imaging and surgical tools that allow for precise stent placement, particularly in complex cases such as biliopancreatic leakages and pancreatic cancer.

Moreover, the capacity to manage post-operative care and monitor patients for potential complications, such as stent migration or infections, has positioned hospitals as the preferred setting for biliary stent procedures. The higher patient inflow for major surgical interventions has also been seen as a factor consolidating the leadership of hospitals in this market segment.

What are the Potential Factors Driving the Growth of Biliary Metal Stents over Plastic Stents in the Market?

According to VMR Analyst, the growing preference for biliary metal stents over plastic stents has been attributed to their longer patency rates and reduced need for frequent replacements. Metal stents, particularly self-expanding metal stents (SEMS), have been found to be more durable and resistant to occlusion, making them more suitable for chronic conditions like pancreatic cancer and benign biliary strictures.

Additionally, the capability of metal stents to maintain lumen patency for extended periods has been highlighted as a key advantage in reducing hospital readmissions and intervention costs. Although plastic stents remain a cost-effective solution for temporary conditions, metal stents are being increasingly adopted due to their enhanced performance and longevity in managing long-term biliary obstructions.

Country/Region-wise Acumens

What are the Key Factors Contributing to North America's Dominance in the Biliary Stents Market?

According to VMR Analyst, North America's dominance in the biliary stents market has been primarily attributed to the region's advanced healthcare infrastructure and the high prevalence of biliary diseases, such as pancreatic cancer and gallstones. According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), approximately 10-15% of adults in the United States have gallstones, representing about 25 million people.

Increased adoption of innovative stenting technologies, coupled with significant healthcare expenditure, has further strengthened the region's market position. The presence of leading medical device manufacturers and well-established reimbursement policies has facilitated access to cutting-edge biliary stent solutions. Additionally, the rising geriatric population, which is more susceptible to biliary conditions, has been recognized as a significant factor driving market growth in North America.

How is the Rapidly Growing Healthcare Sector in the Asia Pacific Influencing the Biliary Stents Market?

According to VMR Analyst, the rapidly expanding healthcare sector in the Asia Pacific has significantly influenced the growth of the biliary stents market in the region. Increasing investments in healthcare infrastructure, along with the rising prevalence of biliary disorders, have been noted as key factors driving market demand.

The Asia Pacific region is experiencing a rapid demographic shift toward an aging population, which is associated with a higher risk of biliary diseases. According to the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), the number of people aged 65 and above in the region is projected to increase from 612 million in 2022 to approximately 1.3 billion by 2050.

Countries such as China, India, and Japan have seen growing adoption of minimally invasive procedures, supported by favorable government initiatives and improved access to healthcare. Additionally, the rising awareness about advanced biliary treatments and the increasing affordability of stent procedures have contributed to the robust growth of the biliary stents market in the Asia Pacific.

Competitive Landscape

The Biliary Stents Market's competitive landscape is characterized by a varied range of companies, including technology developers, plant operators, and service providers, all striving for market share in an increasingly dynamic and growing industry.

Some of the prominent players operating in the biliary stents market include:

Allium Medical Solutions Ltd.

Boston Scientific Corporation

Conmed Corporation

Cook Medical LLC

Dispomedica GmbH

ELLA-CS, s.r.o.

ENDO-FLEX GmbH

ETERMED

Gadelius Medical K.K.

I. Tech Co., Ltd.

Medi-Globe GmbH

Medi-Globe Technologies GmbH

Medtronic plc

Merit Medical Systems, Inc.

Micro-Tech (Nanjing) Co., Ltd.

Olympus Corporation

Optimed Medizinische Instrumente GmbH

Bard (acquired by BD)

Taewoong Medical Co., Ltd.

Xlumena, Inc. (acquired by Boston Scientific)

Latest Developments

In February 2023, Olympus Corporation announced the acquisition of Taewoong Medical, a South Korean manufacturer of gastrointestinal (including biliary tract) metallic stents. Taewoong will receive $370 million in cash under the agreement, with $255.5 million paid at closing and the remaining $114.5 million paid based on future milestones. In May 2021, amg International GmbH, a wholly owned subsidiary of Dublin, Ireland-based Q3 Medical Devices Limited (Q3), strengthens its position as a leader in the rapid development of novel biodegradable implants. The Company announced that its second fully biodegradable product, the UNITY-B balloon expandable biodegradable biliary stent (BEBS) for endoscopic use, has received CE Mark approval. The UNITY-B will be used in conjunction with the ARCHIMEDESTM, the world's first CE-approved pancreaticobiliary biodegradable implant.

1 INTRODUCTION OF GLOBAL BILIARY STENTS MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL BILIARY STENTS MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL BILIARY STENTS MARKET, BY PRODUCT

5.1 Overview
5.2 Biliary Metal Stents
5.3 Biliary Plastic Stent

6 GLOBAL BILIARY STENTS MARKET, BY END-USER

6.1 Overview
6.2 Hospitals
6.3 Ambulatory Surgical Centers

7 GLOBAL BILIARY STENTS MARKET, BY APPLICATION

7.1 Overview
7.2 Bilio-pancreatic Leakages
7.3 Pancreatic Cancer
7.4 Benign Biliary Strictures
7.5 Gallstones

8 GLOBAL BILIARY STENTS MARKET, BY GEOGRAPHY

8.1 Overview
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest of Asia Pacific
8.5 Rest of the World
- 8.5.1 Latin America
- 8.5.2 Middle East and Africa

9 GLOBAL BILIARY STENTS MARKET COMPETITIVE LANDSCAPE

9.1 Overview
9.2 Company Market Ranking
9.3 Key Development Strategies

10 COMPANY PROFILES

10.1 Allium Medical Solutions
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
10.2 Boston Scientific Corporation
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
10.3 Conmed Corporation
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
10.4 Cook Medical LLC
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
10.5 Dispomedica GmbH
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
10.6 ELLA-CS
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
10.7 s.r.o
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
10.8 ENDO-FLEX GmbH
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
10.9 Gadelius Medical K.K.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
10.10 I Tech Co., Ltd.
- 10.10.1 Overview
- 10.10.2 Financial Performance
- 10.10.3 Product Outlook
- 10.10.4 Key Developments
10.11 Medi-Globe GmbH
- 10.11.1 Overview
- 10.11.2 Financial Performance
- 10.11.3 Product Outlook
- 10.11.4 Key Developments
10.12 Medi-Globe Technologies GmbH
- 10.12.1 Overview
- 10.12.2 Financial Performance
- 10.12.3 Product Outlook
- 10.12.4 Key Developments
10.13 Medtronic plc
- 10.13.1 Overview
- 10.13.2 Financial Performance
- 10.13.3 Product Outlook
- 10.13.4 Key Developments
10.14 Merit Medical Systems, Inc.
- 10.14.1 Overview
- 10.14.2 Financial Performance
- 10.14.3 Product Outlook
- 10.14.4 Key Developments
10.15 Micro-Tech (Nanjing) Co., Ltd.
- 10.15.1 Overview
- 10.15.2 Financial Performance
- 10.15.3 Product Outlook
- 10.15.4 Key Developments
10.16 Olympus Corporation
- 10.16.1 Overview
- 10.16.2 Financial Performance
- 10.16.3 Product Outlook
- 10.16.4 Key Developments
10.17 Optimed Medizinische Instrumente GmbH
- 10.17.1 Overview
- 10.17.2 Financial Performance
- 10.17.3 Product Outlook
- 10.17.4 Key Developments
10.18 Bard (acquired by BD)
- 10.18.1 Overview
- 10.18.2 Financial Performance
- 10.18.3 Product Outlook
- 10.18.4 Key Developments
10.19 Taewoong Medical Co., Ltd.
- 10.19.1 Overview
- 10.19.2 Financial Performance
- 10.19.3 Product Outlook
- 10.19.4 Key Developments
10.20 Xlumena, Inc. (acquired by Boston Scientific)
- 10.20.1 Overview
- 10.20.2 Financial Performance
- 10.20.3 Product Outlook
- 10.20.4 Key Developments

11 KEY DEVELOPMENTS

11.1 Product Launches/Developments
11.2 Mergers and Acquisitions
11.3 Business Expansions
11.4 Partnerships and Collaborations

12 Appendix

12.1 Related Research

02-2729-4219

+886-2-2729-4219

License/价格

2026 年至 2032 年胆道支架市场（按产品、最终用户、应用和地区划分）

Biliary Stents Market by Product (Biliary Metal Stents, Biliary Plastic Stents), End-User (Hospitals, Ambulatory Surgical Centers), Application (Biliopancreatic Leakages, Pancreatic Cancer, Benign Biliary Strictures, Gallstones), & Region for 2026-2032

2026-2032年胆道支架市场评估

影响胆道支架市场成长的主要限制因素有哪些？

目录

第一章全球胆道支架市场介绍

第二章执行摘要

第三章：已验证的市场研究调查方法

第四章 胆道支架的全球市场展望

5. 全球胆道支架市场（按产品）

6. 全球胆道支架市场（依最终用户）

7. 全球胆道支架市场（依应用）

8. 全球胆道支架市场（按地区）

第九章全球胆道支架市场的竞争格局

第十章 公司简介

第十一章 重大进展

第十二章 附录